Sino-U.S. trade hopes lift FTSE 100; TUI slumps
(For a live blog on European stocks, type LIVE/ in an Eikon news window)
* FTSE 100 up 0.6 pct
* FTSE 250 up 0.5 pct
* U.S.-China trade hopes help miners gain
* TUI slumps after profit warning
* AstraZeneca down after cancer drug tie-up
March 29 (Reuters) - Britain's FTSE 100 thrived as hopes of progress in the latest round of Sino-U.S. trade talks ignited optimism, while tour operator TUI tumbled after a profit warning and AstraZeneca weakened after a $6.9 billion cancer drug tie-up.
The FTSE 100 .FTSE gained 0.6 percent and the FTSE 250 .FTMC added 0.5 percent by 0836 GMT.
Optimism surrounding trade talks between China and the United States, to be kicked off on Friday, buoyed miners .FTNMX1770 . Asia-exposed financial heavyweights HSBC HSBA.L and Prudential PRU.L also rose.
Sentiment was aided by comments from U.S. Treasury Secretary Steven Mnuchin that he and U.S. Trade Representative Robert Lighthizer had concluded "constructive" trade talks in Beijing. majors also gained as crude prices rose and were set for their biggest quarterly rise since 2009. O/R
But London-listed shares of TUI TUIT.L slumped 9.9 percent to the bottom of the main bourse and hit a record low after the German tour operator issued a profit warning due to grounding of Boeing's BA.N 737 MAX aircrafts in the wake of two deadly crashes of the model. AZN.L slipped 3.6 percent after a cancer drug deal with Daiichi Sankyo 4568.T that would have the British drugmaker pay as much as $6.9 billion to its Japanese partner. home, the situation remains uncertain as lawmakers get set to vote on Prime Minister Theresa May's withdrawal agreement at a special sitting - but not on the framework for future relations with the EU she negotiated at the same time. Britain was originally scheduled to leave the EU on Friday. changes drove some moves on the mid-cap index.
Independent alternative investment manager Man Group EMG.L advanced 3.7 percent after Credit Suisse (SIX: CSGN ) initiated coverage with an "outperform" rating, while specialty chemicals maker Victrex VCTX.L gave up 4 percent after Barclays (LON: BARC ) cut price target.
Add Chart to Comment
We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
- Enrich the conversation
- Stay focused and on track. Only post material that’s relevant to the topic being discussed.
- Be respectful. Even negative opinions can be framed positively and diplomatically.
- Use standard writing style. Include punctuation and upper and lower cases.
- NOTE: Spam and/or promotional messages and links within a comment will be removed
- Avoid profanity, slander or personal attacks directed at an author or another user.
- Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
- Only English comments will be allowed.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.
Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb
Drop an image here or